Valion Bio, Inc. (Nasdaq: VBIO) announced that its board of directors has declared a 1-for-25 reverse stock split of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE